SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934
Date of Report (Date of earliest event reported) June 10, 2013
Cigna Corporation
(Exact name of registrant as specified in its charter)
|
Delaware
(State or other jurisdiction of incorporation)
|
1-08323
(Commission File Number)
|
06-1059331
(IRS Employer
Identification No.)
|
900 Cottage Grove Road
Bloomfield, Connecticut 06002
(Address of principal executive offices) (Zip Code)
Registrant's telephone number, including area code:
(860) 226-6000
Not Applicable
(Former name or former address, if changed since last report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
[ ] Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
[ ] Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
[ ] Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
[ ] Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Item 7.01 Regulation FD Disclosure.
On June 10, 2013, Cigna Corporation (“Cigna”) issued a joint press release with Catamaran Corporation (“Catamaran”) announcing the entry into a pharmacy benefit management services agreement. A copy of the joint press release is furnished as Exhibit 99.1 to this Current Report on Form 8-K.
Cigna will be hosting a conference call this afternoon beginning at 5:00 p.m. ET to discuss the transaction. The call-in numbers for the conference call are as follows:
Live Call
(800) 619-9569 (Domestic)
(517) 623-4948 (International)
Passcode: 333521
Replay
(888) 568-0868 (Domestic)
(203) 369-3782 (International)
No Passcode Required
It is strongly suggested you dial in to the conference call by 4:45 p.m. ET. The operator will periodically provide instructions regarding the call.
The information under Item 7.01 in this Form 8-K is being furnished and shall not be deemed “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934, as amended, or otherwise subject to the liabilities of that Section. The information under Item 7.01 in this Form 8-K shall not be incorporated by reference into any registration statement or other document pursuant to the Securities Act of 1933, as amended.
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
| |
Cigna Corporation
|
| |
|
|
| |
|
|
| |
|
|
|
Date: June 10, 2013
|
By:
|
/s/ Ralph J. Nicoletti
|
| |
|
Ralph J. Nicoletti
|
| |
|
Executive Vice President
|
| |
|
and Chief Financial Officer
|
Index to Exhibits
|
Number
|
Description
|
Method of Filing
|
|
|
|
|
|
99.1
|
Joint press release dated June 10, 2013.
|
|